Vitamin D3 for Life

Live Enlightened

Article

Skin Vitamin D Synthesis, Local Activation and Signalling: Full Evidence Review

Previous related pageEvolutionary Context of Vitamin DNext related pageSkin Vitamin D Synthesis, Local Activation and Signalling: Study Summary
Study at a glance

How were vitamin D production and local responses studied in skin?

Two studies examined different roles of skin in the vitamin D system. One exposed 75 healthy young adults with fair skin to controlled ultraviolet light and measured a vitamin D blood marker. The other examined injured skin and skin cells to test local activation of vitamin D and selected defence responses.

How did the light exposure affect vitamin D blood levels?

The blood response depended on the wavelengths used, the area exposed and starting vitamin D levels. Higher starting levels were linked with smaller increases. Different groups received partial-body or full-body exposure, so their average changes were not a clean test of exposed area alone. Some lamps included wavelengths not normally present in sunlight at ground level.

How did skin cells activate vitamin D and respond to injury?

An injury-related signal increased an enzyme that activates a vitamin D precursor, a starting form of vitamin D. When this precursor was available, selected responses for fighting and recognising microbes increased. Experiments that blocked activation or receptor signalling supported parts of this pathway. Responses that act against microbes in humans and mice did not behave identically, so the species findings cannot be treated as interchangeable.

Do these findings establish better healing or a safe sun-exposure target?

Skin can help start vitamin D production and can also respond to vitamin D locally. The studies did not demonstrate that a rise in the blood marker improved wound healing or prevented infection. The local experiments were small, and the light study did not establish the same response in older people or darker skin. No visible redness during research exposure does not prove absence of damage. These findings do not provide a sun-exposure target, supplement dose or skin treatment.

Read the full article below ↓

Skin participates both in the initiation of vitamin D production and in local responses to active vitamin D. Human ultraviolet-exposure research and skin-cell experiments examine different parts of this system. Their findings connect photochemistry, metabolism and signalling without establishing a sun-exposure prescription or a skin-disease treatment. The companion appraisal is Skin Vitamin D Synthesis, Local Activation and Signalling: Study Summary.

A synthesis of two different experimental questions

Young and colleagues studied how different ultraviolet spectra changed serum 25-hydroxyvitamin D3 after controlled exposure of volunteers. Schauber and colleagues investigated injury-associated activation and antimicrobial signalling in skin and keratinocytes. The first study connects an exposure at the skin to a systemic marker. The second examines how local tissue conditions regulate a vitamin D-related response.

These experiments should not be treated as one continuous pathway measured in the same participants. The ultraviolet study did not measure local calcitriol signalling in a wound, and the injury study did not establish the wavelength dependence of vitamin D photoproduction. Reading them together is useful precisely because it distinguishes production, subsequent metabolism and cellular response. The wider context is Vitamin D and Skin.

The human ultraviolet-exposure study

The study included 75 healthy young adults with fair Fitzpatrick skin types I or II. Thirty-five took part in partial-body exposure experiments and forty in full-body experiments. Partial-body exposure covered approximately 3.7% of body surface area; full-body exposure covered approximately 85%. These were different experimental groups, not a single set of people repeatedly switched between the two areas.

Five ultraviolet sources supplied different mixtures of wavelengths across the two experiments. Each volunteer received five exposures separated by several days. Exposure was specified using standard erythema doses, a measure weighted for the ability to cause skin redness. The protocol did not produce visible erythema. That observation concerns the reported skin response during this experiment; it is not proof that the exposure caused no molecular damage or that a similar schedule is appropriate outside research.

Blood samples were analysed by liquid chromatography tandem mass spectrometry. Samples from a volunteer were assessed together, with duplicate measurements in a second run. The endpoint was circulating 25-hydroxyvitamin D3. It reflects production and downstream handling, so it is not a direct count of vitamin D molecules generated at every skin site. The distinction matters when connecting the experiment to Vitamin D and Sun.

Why wavelength and exposure area matter

An action spectrum describes how effectively different wavelengths produce an endpoint. It is different from the emission spectrum of a lamp, which describes the radiation the lamp delivers. To compare lamps, the investigators weighted their emissions according to proposed biological effectiveness. If the weighting worked well, different sources would give comparable relationships between weighted exposure and the blood-marker response.

Weighting for erythema did not make the vitamin D responses equivalent across sources. Nor did the existing previtamin D action spectrum fully account for the findings when a source contained short wavelengths not normally present in terrestrial sunlight. The authors tested small shifts of that spectrum and found the best combined fit with a five-nanometre shift towards shorter wavelengths. Other nearby shifts were also compatible with parts of the data, so the result should not be presented as an exact, universally established optimum.

The distinction between solar-like sources and those containing nonsolar wavelengths is central. A lamp can increase a blood marker more than expected from its erythema-weighted dose without being a realistic model of ordinary sunshine. The experiment helps explain why laboratory exposure studies cannot always be translated using a single number such as minutes of light or redness-producing dose.

What the blood results do and do not establish

Mean increases in serum 25-hydroxyvitamin D3 were approximately 11.0 nmol/L in the pooled partial-body experiments and 36.1 nmol/L in the pooled full-body experiments. These pooled values came from different exposure areas and source groups. They should not be used as a clean randomised estimate of the benefit of exposing more skin. Individual responses varied substantially.

Baseline concentrations also influenced the response: higher starting values were associated with smaller increases. The modelling incorporated baseline rather than relying only on the final change. This is important because differences in starting status can affect comparisons between groups and studies even when the nominal exposure is similar.

The study did not include a contemporaneous unexposed control group within these experiments. The authors referred to controls from other work to argue that short-term changes unrelated to irradiation were unlikely to explain their findings. That supporting argument is not equivalent to having a randomised no-exposure comparator in the present dataset. The study also cannot establish the same quantitative response in older people, darker skin types or people with relevant illness.

Photoproduction is only the beginning

The biochemical sequence begins with a light-driven change in a skin precursor, followed by conversion into vitamin D3. Further hydroxylation is needed to produce the circulating status marker and the active hormone. These stages are described in Vitamin D Activation. A study measuring serum 25-hydroxyvitamin D after skin exposure does not, by itself, localise every subsequent metabolic reaction to the skin.

This is where local tissue experiments answer a complementary question. A keratinocyte can respond to active vitamin D only if the relevant response machinery is present and functional. Vitamin D Receptors describes the recognition step, while Vitamin D and Gene Expression explains why the resulting response can involve a selective set of genes. Neither receptor detection nor an enzyme transcript alone proves that a clinically important amount of active hormone was generated locally.

Schauber and colleagues examined wounded human skin and keratinocytes. In culture, the wound-associated signal TGF-beta1 increased CYP27B1, the enzyme that activates a vitamin D precursor. With precursor available, cathelicidin, CD14 and TLR2 responses increased. These molecules have different jobs: cathelicidin is an antimicrobial peptide, while CD14 and TLR2 participate in microbial recognition.

Itraconazole, used to inhibit activation, and a VDR antagonist suppressed the responses. Removing the vitamin D response element from a cathelicidin promoter reporter impaired its response. A separate TLR2-blocking antibody experiment tested microbial-signal responsiveness. These controls address conversion, receptor signalling, a regulatory DNA sequence and microbial recognition respectively; they are not interchangeable demonstrations of the same step.

CYP27B1-deficient mice failed to increase wound-associated CD14 normally, but their cathelicidin still increased. The human antimicrobial pathway therefore should not be imposed unchanged on mice. The paper also gives inconsistent TGF-beta1 concentrations in one figure caption and the methods; a single exact concentration cannot be treated as resolved.

Defence, differentiation and barrier function are distinct endpoints

The local-signalling results concern selected antimicrobial and innate-recognition responses. They are relevant to Vitamin D and Barrier Immunity and Vitamin D and Antimicrobial Peptides. Increased expression of an antimicrobial gene does not demonstrate that a wound closed faster or that an infection was prevented. The experiments did not establish those patient outcomes.

Skin maintenance also depends on orderly cell maturation, discussed in Vitamin D and Cell Differentiation. It would be misleading to use a defence-related transcriptional result as a complete assay of differentiation or epidermal turnover. A study must measure cell-state changes, replacement or physical barrier properties if it is to support those more specific claims.

The human observations and the cell experiments consequently have different roles. The observations place the proposed pathway in a relevant tissue setting; the controlled experiments test parts of its regulation. Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1) explains the metabolic control point. Neither line of evidence removes the need for clinical studies that measure meaningful outcomes and distinguish vitamin D-related responses from other injury and repair signals.

How the evidence fits together

The human exposure study shows why wavelength composition, exposed area and starting status matter when interpreting vitamin D production after ultraviolet exposure. The skin-signalling study shows that local injury-related conditions can regulate a vitamin D-dependent response. Together they support a model in which the skin is both an entry point for vitamin D production and a tissue with its own response machinery.

The connection remains conditional. A rise in the circulating status marker does not prove that local antimicrobial signalling improved, and a response in a keratinocyte culture does not establish a safe or effective exposure schedule. The studies used different populations, preparations, interventions and endpoints. Their agreement at the level of biological plausibility cannot substitute for a measured clinical chain of benefit.

The scale of the local skin experiments

The human injury comparison was small: five wounded-skin samples were compared with four controls at the reported early time point. A separate topical experiment involved seven volunteers with a within-person comparison. These designs are useful for locating an early biological response, but their sample sizes and short observation periods cannot establish an uncommon adverse effect or a durable clinical benefit.

The mouse component also needs its own boundary. Human cathelicidin regulation through vitamin D-responsive DNA is not reproduced identically in mice. Consequently, an enzyme-deficiency result in a mouse can support a role for local activation while still being an imperfect model of the human antimicrobial response. The most informative interpretation keeps the species-specific gene regulation visible rather than describing all the experiments as equivalent confirmation.

Conclusion

The evidence supports distinct roles for the skin in vitamin D photoproduction and in local metabolism and signalling. It also shows why those roles need separate measurements. These studies help explain the system; they do not establish an individual ultraviolet-exposure target, a supplement dose or a treatment for a skin condition.

Sources and publication details

A revised action spectrum for vitamin D synthesis by suberythemal UV radiation exposure in humans in vivo. Young AR and colleagues. Proceedings of the National Academy of Sciences of the United States of America. 2021;118(40):e2015867118. DOI: 10.1073/pnas.2015867118. PMID: 34580202.

Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. Schauber J and colleagues. Journal of Clinical Investigation. 2007;117:803 to 811. DOI: 10.1172/JCI30142.

Related reading

Original sources

Source

A revised action spectrum for vitamin D synthesis by suberythemal UV radiation exposure in humans in vivo

Solar UV radiation (UVR) causes sunburn but initiates the first step of vitamin D synthesis, which is the formation of previtamin D3 (pre-D3) in skin.

Publication details

A revised action spectrum for vitamin D synthesis by suberythemal UV radiation exposure in humans in vivo. Young AR and colleagues. Proceedings of the National Academy of Sciences of the United States of America. 2021;118(40):e2015867118. DOI: 10.1073/pnas.2015867118. PMID: 34580202.

Read more →